Search research articles
Contact Us
Filters
Showing results (11-20 of 36) with videos related to
Page
of 4
Sort By:
Proceedings of the National Academy of Sciences of the United States of America
|
April 4, 2013
Autoantigen can promote progression to a more aggressive TCL1 leukemia by selecting variants with enhanced B-cell receptor signaling
Shih-Shih Chen, Franak Batliwalla, Nichol E Holodick, et al.
Blood
|
December 20, 2011
The Bruton tyrosine kinase inhibitor PCI-32765 thwarts chronic lymphocytic leukemia cell survival and tissue homing in vitro and in vivo
Sabine Ponader, Shih-Shih Chen, Joseph J Buggy, et al.
Blood
|
October 23, 2024
Deuterated water labeling in ibrutinib-treated patients with CLL: leukemia cell kinetics correlate with IGHV, ZAP-70, and MRD
Ekaterina Kim, Shih-Shih Chen, Mariela Sivina, et al.
Frontiers in Immunology
|
March 26, 2021
A Detailed Analysis of Parameters Supporting the Engraftment and Growth of Chronic Lymphocytic Leukemia Cells in Immune-Deficient Mice
Piers E M Patten, Gerardo Ferrer, Shih-Shih Chen, et al.
Leukemia
|
October 22, 2020
CXCL13 plasma levels function as a biomarker for disease activity in patients with chronic lymphocytic leukemia
Mariela Sivina, Lianchun Xiao, Ekaterina Kim, et al.
Blood
|
November 25, 2010
Silencing of the inhibitor of DNA binding protein 4 (ID4) contributes to the pathogenesis of mouse and human CLL
Shih-Shih Chen, Rainer Claus, David M Lucas, et al.
Oncotarget
|
March 31, 2016
A combination of an anti-SLAMF6 antibody and ibrutinib efficiently abrogates expansion of chronic lymphocytic leukemia cells
Burcu Yigit, Peter J Halibozek, Shih-Shih Chen, et al.
Leukemia
|
November 23, 2024
CLL crosstalk with naïve T cells enhances the differentiation of IL-22-producing T cells and CLL -cell survival
Gerardo Ferrer, Florencia Palacios, Pui Yan Chiu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 25, 2017
Combined BTK and PI3Kδ Inhibition with Acalabrutinib and ACP-319 Improves Survival and Tumor Control in CLL Mouse Model
Carsten U Niemann, Helena I Mora-Jensen, Eman L Dadashian, et al.
Cancer Research
|
May 3, 2008
Epigenetic modification of CCAAT/enhancer binding protein alpha expression in acute myeloid leukemia
Björn Hackanson, Kristi L Bennett, Romulo M Brena, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 36) with videos related to
Sort By:
Page
of 4
Proceedings of the National Academy of Sciences of the United States of America
|
April 4, 2013
Autoantigen can promote progression to a more aggressive TCL1 leukemia by selecting variants with enhanced B-cell receptor signaling
Shih-Shih Chen, Franak Batliwalla, Nichol E Holodick, et al.
Blood
|
December 20, 2011
The Bruton tyrosine kinase inhibitor PCI-32765 thwarts chronic lymphocytic leukemia cell survival and tissue homing in vitro and in vivo
Sabine Ponader, Shih-Shih Chen, Joseph J Buggy, et al.
Blood
|
October 23, 2024
Deuterated water labeling in ibrutinib-treated patients with CLL: leukemia cell kinetics correlate with IGHV, ZAP-70, and MRD
Ekaterina Kim, Shih-Shih Chen, Mariela Sivina, et al.
Frontiers in Immunology
|
March 26, 2021
A Detailed Analysis of Parameters Supporting the Engraftment and Growth of Chronic Lymphocytic Leukemia Cells in Immune-Deficient Mice
Piers E M Patten, Gerardo Ferrer, Shih-Shih Chen, et al.
Leukemia
|
October 22, 2020
CXCL13 plasma levels function as a biomarker for disease activity in patients with chronic lymphocytic leukemia
Mariela Sivina, Lianchun Xiao, Ekaterina Kim, et al.
Blood
|
November 25, 2010
Silencing of the inhibitor of DNA binding protein 4 (ID4) contributes to the pathogenesis of mouse and human CLL
Shih-Shih Chen, Rainer Claus, David M Lucas, et al.
Oncotarget
|
March 31, 2016
A combination of an anti-SLAMF6 antibody and ibrutinib efficiently abrogates expansion of chronic lymphocytic leukemia cells
Burcu Yigit, Peter J Halibozek, Shih-Shih Chen, et al.
Leukemia
|
November 23, 2024
CLL crosstalk with naïve T cells enhances the differentiation of IL-22-producing T cells and CLL -cell survival
Gerardo Ferrer, Florencia Palacios, Pui Yan Chiu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 25, 2017
Combined BTK and PI3Kδ Inhibition with Acalabrutinib and ACP-319 Improves Survival and Tumor Control in CLL Mouse Model
Carsten U Niemann, Helena I Mora-Jensen, Eman L Dadashian, et al.
Cancer Research
|
May 3, 2008
Epigenetic modification of CCAAT/enhancer binding protein alpha expression in acute myeloid leukemia
Björn Hackanson, Kristi L Bennett, Romulo M Brena, et al.
Page
of 4